Piramal Pharma Solutions
Lexington, KY · Riverview, MI · Ahmedabad, IN
Program data pending ClinicalTrials.gov matching
· Last scored 2026-03-15
70.5
Signal Score
✓ FDA Inspections (1)
○ Clinical Trials
○ SEC Filings
✓ Press (6)
Quick Facts: Piramal Pharma Solutions
- Signal Score
- 70.5/100 (as of 2026-03-15)
- Quality Compliance
- Assessment pending
- Headquarters
- Lexington, KY · Riverview, MI · Ahmedabad, IN
- Modalities
- Biologics
- Active CGT Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CGT manufacturing intelligence platform
Signal Score & Pillar Breakdown
Quality Compliance
—
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA Inspections1 on record
Warning Letters0
Last InspectionVoluntary Action Indicated (VAI) (2025-02-17)
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesBiologics
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
83.0
Publicly traded — financial transparency
Source: SEC EDGAR, press monitoring
Subsidiary of Piramal Group
SEC FilingsParent: Piramal Group
Publicly traded — financial transparency
Capacity
58.0
3 CGT manufacturing sites
Sites: Lexington, KY, Riverview, MI, Ahmedabad, India
Source: SEC EDGAR, press monitoring, company profiles
3 CGT manufacturing sites
Recent Press6 articles
3 CGT manufacturing sites
FDA Inspection History
2025-02
NAI
VAI
OAI
| Date | Site | Type | Observations | Classification |
|---|---|---|---|---|
| 2025-02-17 | Navi Mumbai | Drug Quality Assurance | No | Voluntary Action Indicated (VAI) |
Source: FDA Data Dashboard · Retrieved Mar 20, 2026
Recent News 6 articles
Piramal Pharma Solutions' Grangemouth, UK Facility Successfully Delivers 1,500th ADC Batch - PR Newswire
Piramal Pharma Solutions' Grangemouth, UK Facility Successfully Delivers 1,500th ADC Batch PR Newswire
Piramal Pharma Solutions' Grangemouth, UK Facility Successfully Delivers 1,500th ADC Batch - Morningstar
Piramal Pharma Solutions' Grangemouth, UK Facility Successfully Delivers 1,500th ADC Batch Morningstar
Piramal Pharma Solutions' Grangemouth, UK Facility Successfully Delivers 1,500th ADC Batch | Corporate - EQS News
Piramal Pharma Solutions' Grangemouth, UK Facility Successfully Delivers 1,500th ADC Batch | Corporate EQS News
Piramal Pharma Solutions Completes 1,500th ADC Batch at Grangemouth Facility - Contract Pharma
Piramal Pharma Solutions Completes 1,500th ADC Batch at Grangemouth Facility Contract Pharma
Payload-Linker Engineering as a Differentiator in ADC Development and Manufacturing - Contract Pharma
Payload-Linker Engineering as a Differentiator in ADC Development and Manufacturing Contract Pharma
Advancing ADC Manufacturing and Supply Chain Solutions - BioPharm International
Advancing ADC Manufacturing and Supply Chain Solutions BioPharm International
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in: